Can inflammation reduce thyroid hormone signaling?

Systemic inflammation alters thyroid homeostasis—a state often clinically manifested as non-thyroidal illness syndrome—by directly disrupting intracellular thyroid hormone processing and sensitivity.

Mechanistic pathways of thyroid disruption

• Deiodinase dysregulation: Inflammatory cytokines (such as IL-6, TNF-alpha, and IL-1beta) suppress the expression and catalytic function of type 1 (D1) and type 2 (D2) deiodinases, which convert thyroxine (T4) to active triiodothyronine (T3). Concurrently, inflammation upregulates type 3 deiodinase (D3), accelerating thyroid hormone degradation.
• Oxidative stress compounding: Cytokine-driven inflammatory processes trigger systemic oxidative stress and accumulate reactive oxygen species. This oxidative environment impairs deiodinase function by depleting or oxidizing the vital thiol cofactors necessary for D1 and D2 catalytic activity.
• Receptor-level resistance: Inflammation induces functional, tissue-specific thyroid hormone resistance. Nuclear factor-kappaB (NF-kB) activation and systemic cytokines suppress nuclear T3 receptor binding capacity and impair the recruitment of critical transcriptional co-activators like SRC-1, silencing downstream thyroid-dependent gene programs.

Bidirectional inflammatory feedback

• The feedback loop: A crucial bidirectional relationship exists. While inflammation actively impairs thyroid signaling, robust thyroid hormone receptor activation normally suppresses NF-kB activation and downregulates pro-inflammatory cytokine production. Thus, inflammation-induced thyroid resistance can trap tissues in a self-perpetuating, pro-inflammatory cycle.

Bottom line

• Key takeaway: Systemic inflammation dampens tissue-level thyroid signaling through a dual mechanism: it enzymatically starves tissues of active T3 by altering deiodinase activity (mediated by oxidative stress and thiol depletion) and physically impedes thyroid receptor transcription by blocking co-activator recruitment.